...

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adagloxad simolenin (OBI-822) and OBI-821 treatment in patients with early-stage triple-negative breast cancer (TNBC) at high risk for recurrence

【24h】

Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adagloxad simolenin (OBI-822) and OBI-821 treatment in patients with early-stage triple-negative breast cancer (TNBC) at high risk for recurrence

机译：第3阶段，随机，双盲，安慰剂对照研究，评估脂肪醛素（OBI-822）和OBI-821治疗在早期三阴性乳腺癌（TNBC）的患者中的疗效和安全性复发

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal 》 |2020年第2020期| 共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adagloxad simolenin (OBI-822) and OBI-821 treatment in patients with early-stage triple-negative breast cancer (TNBC) at high risk for recurrence [J] . Intelligence: A Multidisciplinary Journal . 2020 ,第期

机译：第3阶段，随机，双盲，安慰剂对照研究，评估脂肪醛素（OBI-822）和OBI-821治疗在早期三阴性乳腺癌（TNBC）的患者中的疗效和安全性复发
2. A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide [J] . Eunice S Wang, Roger M Lyons, Richard A Larson, Journal of Hematology and Oncology . 2012 ,第S1期

机译：一项随机，双盲，安慰剂对照的2期研究，评估接受来那度胺治疗的低剂量或中度1风险性骨髓增生异常综合征患者接受romiplostim治疗的有效性和安全性
3. A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain [J] . Webster Lynn R., Yamada Tadaaki, Ferreira Juan Camilo Arjona Pain medicine : . 2017 ,第12期

机译：第2B期，随机双盲安慰剂对照研究，以评估Naldemedine用于治疗慢性非癌症疼痛患者阿片类药物诱导的便秘的疗效和安全性
4. Mobile Health System for Evaluation of Breast Cancer Patients During Treatment and Recovery Phases [C] . Joaquin Ollero, Jose Antonio Moral-Munoz, Ignacio Rojas, International work-conference on bioinformatics and biomedical engineering . 2017

机译：用于评估乳腺癌患者在治疗和康复阶段的移动医疗系统
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized placebo-controlled study [O] . Chiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, 2020

机译：Globo H-KLH疫苗Adagloxad Simolenin（OBI-822）/ OBI-821患者转移乳腺癌患者：II期随机安慰剂对照研究
7. Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study [O] . Chiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, 2020

机译：Globo H-KLH疫苗Adagloxad Simolenin（OBI-822）/ OBI-821患者转移乳腺癌患者：II期随机，安慰剂对照研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号